1LAINE J, KONTrINEN Y T, BELIAEV N, ctal. J Oral Pathol Med,1999,28(3) : 117-121.
2GIROD S C, KUHNAST T, ULRICH S, et al. In Vivo, 1994,8(4):543-547.
3KIRBY A C, LODI G L, OLSEN I, et al. Eur J Oral Sci, 1998,106 (4) :853-862.
4MCCARTAN B E, LAMEY P J. J Oral Pathol Med, 1997,26(4) : 176-180.
5RISSOAN M C, SOUMELIS V, KADOWAKI N, et al. Science, 1999,283(5405) : 1183-1186.
6SANTORO A, MAJORANA A, ROVERSI L, et al. J Pathol, 2005,205(4) :426-434.
7HOLLANDER G A, ZUKLYS S, FORSTER E, et al. Transplant Proc,1999,31 (1-2A) :25s-31s.
8GEIJTENBEEK T B, TORENSMA R, VAN VLIET S J, et al. Cell,2000,100(5) :575-585.
9VAN GISBERGEN K P, GEIJTENBEEK T B, VAN KOOYK Y. Trends Immunol, 2005,26(12) :626-631.
10VAN GISBERGEN K P, LUDWIG I S, GEIJTENBEEK T B, et al. FEBS Lett, 2005,579(27) :6159-6168.
二级参考文献8
1张筱林，中华口腔医学杂志，1984年，19卷，9页
2宋铁生，国外医学皮肤科学分册，1983年，1期，26页
3Auffennann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic,but not resolved,hepatitis C virus infection. Blood,2001,97:3171-3176.
4Schwartz M. A biomathematical approach to clinical tumor growth.Cancer , 1961,14 : 1272-1294.
5Holtl L, Zelle-Rieser C, Gander H, et al. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res, 2002, 8:3369-3376.
6Kowalkowski KL, Alzona MT, Aono FM,et al. Ex vivo generation of dendritic cells from CD34 + cells in gas-permeable containers under serum-free conditions. J Hematother, 1998, 7:403-411.
7Nestle FO, Alijagic S, Gilliet M, et ai. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med,1998,4:328-332.
